4- 2-(Isopropylamino)ethyl!pyrocatechol intraocular pressure lowering process

摘要

Topical administration of 4- 2-(isopropylamino) ethyl!pyrocatechol to the mammalian eye reduces intraocular pressure without side effects generally associated with adrenergic activation such as tachycardia, mydriasis, hypertension and hypotension.